| Literature DB >> 10998705 |
.
Abstract
An overview of the spinal administration of ketamine is presented. Ketamine acts as a noncompetitive antagonist of the NMDA receptor Ca(++ channel pore. This effect provides interesting possibilities in pain therapy. However, there are still contrasting results that seem to be due to a lack of comparative controlled studies. The presence of systemic and neurotoxic effects presently limits clinical use).Entities:
Year: 1999 PMID: 10998705 DOI: 10.1007/s11916-999-0074-1
Source DB: PubMed Journal: Curr Rev Pain ISSN: 1069-5850